The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinomas.
 
Curtis Perry
Research Funding - AstraZeneca (Inst)
 
Alexander Frey
Patents, Royalties, Other Intellectual Property - Patent pending for the use of mRNA vaccine for the treatment of virally associated cancers.
 
Yuewei Fei
No Relationships to Disclose
 
Philippos Costa
No Relationships to Disclose
 
Jason Wang
Employment - Merck (I)
Leadership - Merck (I)
Stock and Other Ownership Interests - Merck (I)
 
Sina Ghadermarzi
No Relationships to Disclose
 
Daniel Levine
No Relationships to Disclose
 
Asuka Koda
No Relationships to Disclose
 
Amin Nassar
Stock and Other Ownership Interests - Revolution Medicines; Summit Therapeutics
Honoraria - Capvision; Guidepoint Global; KSMO; Oklahoma University; Putnam Associates; Targeted Oncology; TEMPUS
Travel, Accommodations, Expenses - American Association for Cancer Research; Korean Society of Medical Oncology (KSMO)
 
Min Ding
No Relationships to Disclose
 
Yunan Nie
No Relationships to Disclose
 
Therese Cordero-Dumit
No Relationships to Disclose
 
Arnaud Augert
No Relationships to Disclose
 
David van Djik
No Relationships to Disclose
 
Kelly Olino
Patents, Royalties, Other Intellectual Property - Patent pending for the use of mRNA vaccine for the treatment of virally associated cancers.
 
Jeffrey Ishizuka
Stock and Other Ownership Interests - Curios Therapeutics; Jounce Therapeutics; Kronos Bio
Consulting or Advisory Role - Danger Bio; Fortress Biotech; Ono Pharmaceutical; Phenomic AI; Rheos Medicines; Tango Therapeutics; Two River Group
Research Funding - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - I am an inventor on a patent on approaches targeting dsRNA sensing titled: "MODULATING dsRNA EDITING, SENSING, AND METABOLISM TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY AND/OR MODULATORS OF INTRATUMORAL INTERFERON".